hotspot -WSS

hotspot

author：entertainment 2025-09-30 00:36:25 - browse：381

When Prozac first entered the psychiatry scene in in the late ’80s, the profession was still Freud’s territory. Many considered taking medication to treat depression a failure. But that was all about to change, as early stewards like psychiatrist Peter Kramer refused to shy away from the new drug’s potential. These days, he says that people take for granted all of the progress that’s been made with antidepressant treatment in the past three decades.

“If you were going to be depressed any time in history and were interested in having an effective treatment, you would want to be alive now. But we’ve lost our wonderment about that,” said Kramer, the author of the groundbreaking 1993 book “Listening to Prozac.”

This week, Kramer joins me to discuss how the country’s relationship with antidepressants has changed since the publication of his book three decades ago. The conversation is based on his First Opinion, “What antidepressants are saying 30 years after the publication of ‘Listening to Prozac.’”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

Previous article： Medical records are filled with copy
Next article： Doctors find melanoma drugs effective against rare brain cancer

WSS

FDA approves RSV monoclonal antibody for infants, toddlers

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

How Medicaid coverage policies for immigrants impact new moms

Key House panel plots a new health care package

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

Startup Neumora takes a novel depression drug to Phase 3

explore

hotspot

focus

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Medicare has a new plan to address drug shortages

Trump demands the U.S. pay no more for drugs than other countries … again

Why hospitals are withdrawing from US News rankings

United colonoscopy coverage change 'may cost lives,' doctors say

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

Anesthesiologist group: stop taking Ozempic before surgery

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

Medical records are filled with copy

AI can’t replace a physician’s gut feeling

focus

Medicare to cover more brain scans for Alzheimer’s patients

In early work, researchers turn to CRISPR to treat Alzheimer's

Key House panel plots a new health care package

Startup Neumora takes a novel depression drug to Phase 3

Group opposing PBM reform sets lobbying record

Medicare to cover more brain scans for Alzheimer’s patients

explore

explore

focus

focus